383 results on '"Vandenbos, Fanny"'
Search Results
2. BRCA1/2 Pathogenic Variants Are Not Common in Merkel Cell Carcinoma: Comprehensive Molecular Study of 30 Cases and Meta-Analysis of the Literature
3. STRN::ALK, a novel fusion to foetal lung interstitial tumour
4. Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
5. High-grade childhood intra-parenchymal brain tumor clustering with ATRT and expanding the cancer spectrum related to inherited SMARCE1 truncating variations
6. Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase
7. A 78‐year‐old woman with diffuse white matter infiltration and predominant involvement of bilateral temporo‐parieto‐occipital regions
8. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
9. Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognizable by a specific epigenetic signature
10. Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection—an application in metabolomics studies
11. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
12. Transforming growth factor β neutralization finely tunes macrophage phenotype in elastase-induced abdominal aortic aneurysm and is associated with an increase of arginase 1 expression in the aorta
13. Is H3 K27M mutation testing relevant in the diagnostic routine of WHO grade 4 gliomas exclusively located in the corpus callosum in adults?
14. An Atypical Heel Pain
15. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3
16. 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
17. The molecular landscape of glioma in patients with Neurofibromatosis 1
18. VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
19. Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
20. Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognisable by a specific epigenetic signature.
21. Identification of Metabolomic Markers in Frozen or Formalin-Fixed and Paraffin-Embedded Samples of Diffuse Glioma from Adults.
22. Urinary ketone body loss leads to degeneration of brain white matter in elderly SLC5A8-deficient mice
23. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review
24. Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
25. Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
26. Supplementary tables S1-S3 from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
27. figure legends and tables from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
28. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author’s reply
29. Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection
30. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas
31. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness
32. A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma
33. Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment
34. Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factors
35. Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using Immunohistochemistry
36. AGAP3: A novelBRAFfusion partner in pediatric pancreatic‐type acinar cell carcinoma
37. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
38. Microfoci of malignant progression in diffuse low-grade gliomas: towards the creation of an intermediate grade in glioma classification?
39. Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
40. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours
41. Human glioblastoma cell motility depends on the activity of the cysteine metabolism enzyme 3‐Mercaptopyruvate sulfurtransferase
42. Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
43. Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
44. AGAP3: A novel BRAF fusion partner in pediatric pancreatic‐type acinar cell carcinoma.
45. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient
46. Injectable Magnetic-Responsive Short-Peptide Supramolecular Hydrogels: Ex Vivo and In Vivo Evaluation
47. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis
48. Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
49. EGFR mutation status in brain metastases of non-small cell lung carcinoma
50. Additional file 1 of Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection���an application in metabolomics studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.